Dalei Chen

3.3k total citations · 4 hit papers
59 papers, 2.5k citations indexed

About

Dalei Chen is a scholar working on Electrical and Electronic Engineering, Atomic and Molecular Physics, and Optics and Psychiatry and Mental health. According to data from OpenAlex, Dalei Chen has authored 59 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Electrical and Electronic Engineering, 14 papers in Atomic and Molecular Physics, and Optics and 14 papers in Psychiatry and Mental health. Recurrent topics in Dalei Chen's work include Advanced Photonic Communication Systems (16 papers), Optical Network Technologies (12 papers) and Advanced Fiber Laser Technologies (12 papers). Dalei Chen is often cited by papers focused on Advanced Photonic Communication Systems (16 papers), Optical Network Technologies (12 papers) and Advanced Fiber Laser Technologies (12 papers). Dalei Chen collaborates with scholars based in China, United States and Denmark. Dalei Chen's co-authors include Alexander Gallus, Michael R. Lassen, Graham F. Pineo, Gary E. Raskob, Philip Hornick, Luz M. Ramirez, Gary E. Raskob, Ronald J. Portman, Maju Mathews and Zhonggao Jiao and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

Dalei Chen

56 papers receiving 2.4k citations

Hit Papers

Apixaban versus enoxaparin for thromboprophylaxis after k... 2009 2026 2014 2020 2010 2010 2009 2023 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
    2010 603 citations Michael R. Lassen, Gary E. Raskob et al. The Lancet profile →
  2. Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement
    2010 583 citations Michael R. Lassen, Alexander Gallus et al. New England Journal of Medicine profile →
  3. Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement
    2009 529 citations Michael R. Lassen, Gary E. Raskob et al. New England Journal of Medicine profile →
  4. Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia
    2023 61 citations Daniel Lee, M Słomkowski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dalei Chen China 19 1.5k 1.5k 328 200 198 59 2.5k
H. Pouleur Belgium 34 64 0.0× 3.3k 2.2× 491 1.5× 48 0.2× 97 0.5× 150 3.9k
Shashank Rohatagi United States 27 326 0.2× 706 0.5× 177 0.5× 3 0.0× 171 0.9× 83 2.2k
Tsuyoshi Shiga Japan 23 87 0.1× 1.2k 0.8× 170 0.5× 10 0.1× 81 0.4× 170 1.8k
Edward L.C. Pritchett United States 42 54 0.0× 5.6k 3.8× 755 2.3× 22 0.1× 160 0.8× 111 6.3k
Ming-Hsiung Hsieh Taiwan 27 150 0.1× 3.8k 2.6× 286 0.9× 7 0.0× 29 0.1× 57 4.3k
Debra S. Echt United States 28 48 0.0× 3.8k 2.6× 359 1.1× 54 0.3× 64 0.3× 64 4.6k
Kevin D. Ballard United States 28 30 0.0× 370 0.2× 158 0.5× 13 0.1× 62 0.3× 76 1.9k
Michael J. Fossler United States 22 122 0.1× 230 0.2× 255 0.8× 5 0.0× 153 0.8× 69 1.5k
Karen J. McClellan New Zealand 27 24 0.0× 531 0.4× 544 1.7× 21 0.1× 205 1.0× 37 2.4k
John V. St. Peter United States 20 54 0.0× 252 0.2× 219 0.7× 6 0.0× 230 1.2× 59 1.8k

Countries citing papers authored by Dalei Chen

Since Specialization
Citations

This map shows the geographic impact of Dalei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalei Chen more than expected).

Fields of papers citing papers by Dalei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalei Chen. The network helps show where Dalei Chen may publish in the future.

Co-authorship network of co-authors of Dalei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Dalei Chen. A scholar is included among the top collaborators of Dalei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalei Chen. Dalei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rothman, Brian, M Słomkowski, A. John Rush, et al.. (2025). A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3 randomized controlled trial (the Mirai study). Journal of Affective Disorders. 388. 119409–119409. 3 indexed citations
2.
3.
4.
5.
Shah, Alpesh, Dalei Chen, Zhen Zhang, et al.. (2024). Efficacy and Safety of Brexpiprazole in Patients with Agitation Associated with Dementia Due to Alzheimer's Disease Analyzed by Presence or Absence of Baseline Psychosis: A Pooled Analysis. American Journal of Geriatric Psychiatry. 32(4). S94–S94. 1 indexed citations
6.
Shah, Alpesh, et al.. (2024). Safety and Tolerability of Brexpiprazole in Adolescents With Schizophrenia: A Long-Term, Open-Label Study. PubMed. 3(2). 313–322. 6 indexed citations
7.
Grossberg, George T., Daniel J. Lee, M Słomkowski, et al.. (2024). Safety, Tolerability, and Efficacy of Brexpiprazole for the Treatment of Agitation Associated with Dementia Due to Alzheimer’s Disease: A 12-week Extension Trial (P11-9.011). Neurology. 102(17_supplement_1). 1 indexed citations
8.
McIntyre, Roger S., Zahinoor Ismail, Maı̈a Miguelez, et al.. (2023). Effects of adjunctive brexpiprazole on patient life engagement in major depressive disorder: Post hoc analysis of Inventory of Depressive Symptomatology Self-Report data. Journal of Psychiatric Research. 162. 71–78. 4 indexed citations
9.
Grossberg, George T., Daniel Lee, M Słomkowski, et al.. (2023). Efficacy, Safety and Tolerability of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. American Journal of Geriatric Psychiatry. 31(3). S99–S100. 2 indexed citations
10.
Newcomer, John W., et al.. (2023). Changes in Metabolic Parameters and Body Weight in Patients With Prediabetes Treated With Adjunctive Brexpiprazole for Major Depressive Disorder. The Journal of Clinical Psychiatry. 84(5). 3 indexed citations
11.
Chen, Dalei, et al.. (2022). Theaflavin Attenuates TBHP-Induced Endothelial Cells Oxidative Stress by Activating PI3K/AKT/Nrf2 and Accelerates Wound Healing in Rats. Frontiers in Bioengineering and Biotechnology. 10. 830574–830574. 14 indexed citations
12.
Marder, Stephen R., et al.. (2021). Effects of Brexpiprazole Across Symptom Domains in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies. Schizophrenia Bulletin Open. 2(1). sgab014–sgab014. 6 indexed citations
13.
Chen, Dalei, Xinzhong Zhang, Jing Yang, et al.. (2021). Codelivery of satraplatin and aminopyrrolic receptor with Pluronic F127-based polyaniline nanoparticles with NIR induced release for combined chemotherapy. Nanotechnology. 32(47). 475103–475103. 2 indexed citations
14.
Liu, Hui, Jiechao Liu, Zhenzhen Lv, et al.. (2019). Effect of dehydration techniques on bioactive compounds in hawthorn slices and their correlations with antioxidant properties. Journal of Food Science and Technology. 56(5). 2446–2457. 37 indexed citations
15.
Clayton, Anita H., Carl Gommoll, Dalei Chen, René Núñez, & Maju Mathews. (2015). Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo. International Clinical Psychopharmacology. 30(4). 216–223. 26 indexed citations
16.
Mathews, Maju, Carl Gommoll, Dalei Chen, René Núñez, & Arif Khan. (2014). Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder. International Clinical Psychopharmacology. 30(2). 67–74. 57 indexed citations
17.
Jain, Rakesh K., Dalei Chen, John Edwards, & Maju Mathews. (2013). Early and sustained improvement with vilazodone in adult patients with major depressive disorder: post hoc analyses of two phase III trials. Current Medical Research and Opinion. 30(2). 263–270. 12 indexed citations
18.
Lassen, Michael R., Gary E. Raskob, Alexander Gallus, et al.. (2010). Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. The Lancet. 375(9717). 807–815. 603 indexed citations breakdown →
19.
Lassen, Michael R., Alexander Gallus, Gary E. Raskob, et al.. (2010). Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement. New England Journal of Medicine. 363(26). 2487–2498. 583 indexed citations breakdown →
20.
Lassen, Michael R., Gary E. Raskob, Alexander Gallus, et al.. (2009). Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement. New England Journal of Medicine. 361(6). 594–604. 529 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Pouleur Breakdown of academic impact, for papers by Shashank Rohatagi Breakdown of academic impact, for papers by Tsuyoshi Shiga Breakdown of academic impact, for papers by Edward L.C. Pritchett Breakdown of academic impact, for papers by Ming-Hsiung Hsieh Breakdown of academic impact, for papers by Debra S. Echt Breakdown of academic impact, for papers by Kevin D. Ballard Breakdown of academic impact, for papers by Michael J. Fossler Breakdown of academic impact, for papers by Karen J. McClellan Breakdown of academic impact, for papers by John V. St. Peter
Rankless by CCL
2026